@ahandvanish How did you find a doctor to help you with your long covid? I have a lot of the symptoms but I don’t know where to go to be evaluate for something like that
@DanielleDuryea2 Clinical research often includes negative data (for instance a paper showing a treatment doesn’t work). In basic/translational research if any negative data is presented I find it buried in the supplementals. I agree it’d be interesting to see more, although it’s probably a lot😅
@DanielleDuryea2 Yeah. I wrote a series of pieces on this a long time ago. Publishing negative results is hugely important (especially in biomedical disciplines). Most folks agree on this. And nothing changes.
I was talking to some ComSciCon participants today. Wouldn’t it be something if there was a way to share negative results from research? Maybe it’s too much info (lol) and probably impractical, but could be potentially helpful information for other scientists. #SciWri22
At #SciWri22#SciWriHook we hear from @DavidQuammen on synecdoche, which he explains as a real fact presented for its relevance as a real fact, but that also has relevance as a symbol or metaphor
At #SciWri22@aznfusion says it’s important to directly state things you do not want to be misinterpreted: specifically, noting the limits to the metaphor presented #SciWriHook
@FleerackersA says “There are limitations to the journal publishing system” and questions whether changes to the preprint reporting system would bring the same flaws as journal publishing #sciwri22#sciwripreprints
@FleerackersA says “science is fundamentally uncertain and could always be proven wrong”. How do we, as journalists or science communicators, make sure to cover science correctly, even aside from preprints? #sciwripreprints#sciwri22
Questions comparing conferences to preprints arise at #sciwripreprints. @FleerackersA says “With a preprint at least you have a whole paper…” as compared to the limited information at a conference, where she comments “how do you even get someone to peer review that” #sciwri22